Q QURIENT Trademark

Trademark Overview


On Thursday, June 16, 2022, a trademark application was filed for Q QURIENT with the United States Patent and Trademark Office. The USPTO has given the Q QURIENT trademark a serial number of 79351503. The federal status of this trademark filing is REGISTERED as of Tuesday, January 9, 2024. This trademark is owned by QURIENT CO., LTD.. The Q QURIENT trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development of vaccines and medicines; development of cell therapy products; drug discovery services; drug development; development of pharmaceutical preparations and medicines; pharmaceutical research and development; pharmaceutical research services; research on the subject of pharmaceuticals; providing of clinical tests of medicines in the nature of product testing, conducting clinical trials for others; pharmaceutical drug development services; scientific research in the field of pharmaceuticals; analysis and evaluation of medical product development; consultancy in the field of testing, inspection, research of medical products; toxicity analysis; scientific research in the field of biomedicine; medical research in the field of crude drugs
q qurient

General Information


Serial Number79351503
Word MarkQ QURIENT
Filing DateThursday, June 16, 2022
Status700 - REGISTERED
Status DateTuesday, January 9, 2024
Registration Number7265380
Registration DateTuesday, January 9, 2024
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, October 24, 2023

Trademark Statements


Description of MarkThe mark consists of the wording "QURIENT" in stylized type, set to the right of a shaded oval above a curving line with a diagonal line extending from the lower right portion thereof, forming a stylized "Q".
Pseudo MarkQ QURIENT
Goods and ServicesResearch and development of vaccines and medicines; development of cell therapy products; drug discovery services; drug development; development of pharmaceutical preparations and medicines; pharmaceutical research and development; pharmaceutical research services; research on the subject of pharmaceuticals; providing of clinical tests of medicines in the nature of product testing, conducting clinical trials for others; pharmaceutical drug development services; scientific research in the field of pharmaceuticals; analysis and evaluation of medical product development; consultancy in the field of testing, inspection, research of medical products; toxicity analysis; scientific research in the field of biomedicine; medical research in the field of crude drugs

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, October 7, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameQURIENT CO., LTD.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressGyeonggi-do 13487
KR

Party NameQURIENT CO., LTD.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGyeonggi-do 13487
KR

Party NameQURIENT CO., LTD.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGyeonggi-do 13487
KR

Trademark Events


Event DateEvent Description
Friday, April 12, 2024FINAL DISPOSITION NOTICE SENT TO IB
Friday, April 12, 2024FINAL DISPOSITION PROCESSED
Tuesday, April 9, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, January 9, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, January 9, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, October 24, 2023NOTIFICATION PROCESSED BY IB
Tuesday, October 24, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 24, 2023PUBLISHED FOR OPPOSITION
Wednesday, October 4, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, October 4, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, October 4, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sunday, September 17, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, September 16, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, September 15, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 15, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, June 26, 2023REFUSAL PROCESSED BY IB
Saturday, June 3, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, June 3, 2023REFUSAL PROCESSED BY MPU
Thursday, April 6, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, April 5, 2023NON-FINAL ACTION WRITTEN
Wednesday, March 29, 2023ASSIGNED TO EXAMINER
Tuesday, October 11, 2022APPLICATION FILING RECEIPT MAILED
Friday, October 7, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, October 6, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB